PEN: Penumbra Inc

PEN新闻

• 13:45 Here's Why Penumbra (PEN) is a Strong Growth Stock
• 16:45 3 Reasons Why Growth Investors Shouldn't Overlook Penumbra (PEN)
• 15:30 Penumbra (PEN) Down 1.6% Since Last Earnings Report: Can It Rebound?
• 12:49 Reasons to Retain Penumbra Stock in Your Portfolio for Now
• 13:10 Lucid Diagnostics Inc. (LUCD) Reports Q4 Loss, Beats Revenue Estimates
• 16:45 Is Penumbra (PEN) a Solid Growth Stock? 3 Reasons to Think "Yes"
• 13:37 瑞银重申Penumbra股票评级,对血栓切除术市场持乐观态度
• 13:32 UBS reiterates Penumbra stock rating on thrombectomy confidence
• 07:55 Fewer Deals, Bigger Stakes: Deciphering The 2026 M&A Landscape And The Rise Of Megadeals
• 12:41 PEN Stock Up Following Q4 Earnings & Revenue Beat, Margins Rise
• 16:42 UBS重申Penumbra股票中性评级,维持$374目标价
• 16:40 UBS reiterates Neutral on Penumbra stock, keeps $374 target
• 21:30 Compared to Estimates, Penumbra (PEN) Q4 Earnings: A Look at Key Metrics
• 21:15 Penumbra (PEN) Surpasses Q4 Earnings and Revenue Estimates
• 20:12 Evercore ISI上调Penumbra目标价,看好栓塞治疗业务增长
• 20:11 Evercore ISI raises Penumbra stock price target on embolization growth
• 16:40 CLPBY or PEN: Which Is the Better Value Stock Right Now?
• 16:26 波士顿科学收购在即,Penumbra财报即将公布
• 15:44 Penumbra earnings on deck as Boston Scientific deal looms
• 02:15 Allspring Growth Fund Q4 2025 Fund Performers And Detractors
• 11:49 Soft Start For $10B-Plus M&A Deals In 2026
• 16:42 波士顿科学季报将至，投资者关注Q3业绩不佳后的反弹与Penumbra收购进展
• 16:41 Boston Scientific earnings on deck after Q3 miss, Penumbra deal
• 16:40 GMED vs. PEN: Which Stock Is the Better Value Option?